Novartis AG Share Holder Equity 2010-2024 | NVS
Novartis AG share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- Novartis AG share holder equity for the quarter ending December 31, 2024 was $44.126B, a 5.61% decline year-over-year.
- Novartis AG share holder equity for 2024 was $44.126B, a 5.61% decline from 2023.
- Novartis AG share holder equity for 2023 was $46.75B, a 21.33% decline from 2022.
- Novartis AG share holder equity for 2022 was $59.423B, a 12.38% decline from 2021.
Novartis AG Annual Share Holder Equity (Millions of US $) |
|
---|---|
2024 | $44,126 |
2023 | $46,750 |
2022 | $59,423 |
2021 | $67,822 |
2020 | $56,666 |
2019 | $55,551 |
2018 | $78,692 |
2017 | $74,227 |
2016 | $74,891 |
2015 | $77,122 |
2014 | $70,844 |
2013 | $74,472 |
2012 | $69,263 |
2011 | $65,940 |
2010 | $69,769 |
2009 | $57,462 |
Novartis AG Quarterly Share Holder Equity (Millions of US $) |
|
---|---|
2024-12-31 | $44,126 |
2024-09-30 | $43,441 |
2024-06-30 | $41,902 |
2024-03-31 | $39,756 |
2023-12-31 | $46,750 |
2023-09-30 | $38,245 |
2023-06-30 | $51,931 |
2023-03-31 | $52,142 |
2022-12-31 | $59,423 |
2022-09-30 | $60,898 |
2022-06-30 | $63,006 |
2022-03-31 | $61,704 |
2021-12-31 | $67,822 |
2021-09-30 | $56,937 |
2021-06-30 | $54,128 |
2021-03-31 | $50,589 |
2020-12-31 | $56,666 |
2020-09-30 | $54,554 |
2020-06-30 | $53,885 |
2020-03-31 | $50,977 |
2019-12-31 | $55,551 |
2019-09-30 | $52,598 |
2019-06-30 | $51,504 |
2019-03-31 | $47,307 |
2018-12-31 | $78,692 |
2018-09-30 | $78,019 |
2018-06-30 | $76,901 |
2018-03-31 | $71,211 |
2017-12-31 | $74,227 |
2017-09-30 | $72,370 |
2017-06-30 | $69,978 |
2017-03-31 | $67,646 |
2016-12-31 |